Trial · NCT05621811
Different Doses of Naronapride vs. Placebo in Gastroparesis
NCT05621811, Phase 2, Completed, Dr. Falk Pharma GmbH
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Different Doses of Naronapride vs. Placebo in Gastroparesis. Trials, record NCT05621811. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05621811
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Different Doses of Naronapride vs. Placebo in Gastroparesis
- NCT number
- NCT05621811
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 328 participants, actual
- Lead sponsor
- Dr. Falk Pharma GmbH
- Conditions
- Gastroparesis
- Interventions
- Naronapride, Placebo
- First posted
- 2022-11-18
- Last updated
- 2026-10-07
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in the American Neurogastroenterology and Motility Society Gastroparesis Cardinal Symptom Index - Daily Diary Total Score at Week 12 | Baseline and Week 12 | ANMS GCSI-DD is a patient-reported outcome instrument for a symptom-based clinical trial endpoint in gastroparesis. The ANMS GCSI-DD core symptom score (total score) included score of nausea, vomiting, early satiety, upper abdominal pain, and postprandial fullness. The severity scores of these symptoms range from 0 (none) to 4 (very severe). For vomiting, the actual number of vomiting episodes was recorded by the participants and capped at 4. Thus, the maximum daily score was 4. The ANMS GCSI-DD core symptom score ranged from 0 to 4 with higher scores reflecting greater symptom severity. A negative change from baseline indicates improvement. The weekly ANMS GCSI-DD score will be calculated as the average of the available daily scores within the 7-day period. Mixed-effects Model for Repeated Measures (MMRM) was used for the analysis. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05621811
GET https://conductscience.org/api/trials/v1/NCT05621811/registered